Discover 602 paid clinical trials in Omaha, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Omaha hosts numerous active clinical trials targeting diseases such as cancer, asthma, and autoimmune disorders like lupus. The city’s leading research institutions are recruiting participants, both as a healthy volunteer and those looking for studies related to specific health conditions, offering opportunities to take part in groundbreaking research and access innovative treatments.
Filter
2
Filter results
Results: 602
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer, PDAC,
Location: Omaha NE, Sioux Falls SD, Kansas City MO, Lawrence KS,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07252232
Phase3, Recruiting
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
for
Symptomatic Genetic Dilated Cardiomyopathy
Location: Omaha NE, Kansas City MO, Rochester MN, Minneapolis MN,
Sponsor: Kardigan, Inc.
Sex: All
Age: 18+
Code: NCT07210723
Phase2, Phase3, Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Omaha NE, Bellevue NE, Carroll IA, Jefferson IA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase3, Recruiting
SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
Get alerts for new trials in your area by subscribing now
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Omaha NE, Kansas City MO, Rochester MN, St Louis MO,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase3, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
for
Locally Advanced Cervical Adenocarcinoma,
Location: Omaha NE, Bellevue NE, Waukee IA, Des Moines IA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07061977
Phase3, Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Location: Omaha NE, Merriam KS, Kansas City MO, Lenexa KS,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06989437
Phase2, Phase3, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Omaha NE, Des Moines IA, Kansas City MO, Wichita KS,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase3, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Omaha NE, Des Moines IA, Sioux Falls SD, Kansas City MO,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase3, Recruiting
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
for
Small Cell Lung Cancer (SCLC),
Location: Omaha NE, Kansas City MO, Memphis TN, Louisville KY,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07472517
Phase3, Recruiting
Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
for
Warm Autoimmune Hemolytic Anemia (WAIHA),
Location: Omaha NE, Rochester MN
Sponsor: CRISPR Therapeutics AG
Sex: All
Age: 18+
Code: NCT07549698
Phase1, Phase2, Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Omaha NE, Kansas City MO, Iowa City IA, Rochester MN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06997497
Phase3, Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Omaha NE, Bellevue NE, Kansas City KS, Fairway KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase2, Recruiting
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
for
Acute Myeloid Leukaemia (AML)
Location: Omaha NE, Birmingham AL, Cleveland OH, Augusta GA,
Sponsor: Moleculin Biotech, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06788756
Phase2, Phase3, Recruiting
Randomization of Single vs Multiple Arterial Grafts
for
Coronary Artery Disease, Heart Diseases
Location: Omaha NE, Lincoln NE, Boulder CO, Winnipeg,
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18 - 70
Code: NCT03217006
Recruiting
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
for
Pulmonary Arterial Hypertension (PAH)
Location: Omaha NE, Aurora CO, Cincinnati OH, Boston MA
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07318597
Phase2, Recruiting
ERAS Protocols in Breast Conserving Surgery
for
Breast Cancer, Postoperative Recovery
Location: Omaha NE
Sponsor: University of Nebraska
Sex: All
Age: 19+
Code: NCT06938581
Recruiting
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib